Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of ZTI-01 vs Monurol in Healthy Subjects
NCT02178254Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cabotegravir in pseudomonas infection (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 6 more. Started Aug 2014; status: completed.
02
Drugs
cabotegravir
03
Conditions
pseudomonas infection
Beyond the preview
Go deeper on NCT02178254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178254.